There’s good news and bad news from the COVID-19 beat. For the bad news, look anywhere news is disseminated. For the good, start with this compact but formidable roundup.  

What are the odds of getting exposed to COVID-19 at a supermarket versus at a restaurant seating customers at every other table? The consensus answer from numerous authoritative voices may surprise you.

Less than half the U.S. public is OK with physicians giving hospital patients’ names to hospital development departments—and that’s after the doctors ask the patients for permission.

As Congress gets to work following its Independence Day break, provider lobbyists are pushing hard for a fifth relief package to stem the bleeding from widespread declines in patient visits. 

Most C-level leaders working in healthcare believe the COVID-19 crisis will come to a close. However, they’re sharply divided over timing.  

The COVID crisis is affecting U.S. healthcare even at the level of high finance, suppressing merger and acquisition activity in the provider sector by almost 20% in 2020’s second quarter versus its first.

Nearly 90% of executives leading medical-technology companies see emerging technologies as a top challenge. And they’re struggling to apply these advances not only to their product and service lines but also to their own business operations.

As the “panic-demic” descended on the U.S. and Canada in March and April, older adults (ages 60 and up) coped better with the stress than both young adults (18–39 years old) and middle agers (40–59).

AI holds the promise of improving gerontology by making it more predictive, personalized, preventive and participatory. However, to get there, an equal number of pronounced risks must be negotiated.  

Patient-facing healthcare workers are neither softened nor hardened in their attitudes toward clinical decision support powered by AI when it’s instead called “AHI,” for augmented human intelligence.